114566-52-8

4-ethyl-6-(2-phenyl-1,3-thiazol-4-yl)-1,4-benzoxazin-3-one

2H-Tetrazole-2-acetic acid,5-(1,5-dimethyl-2,3-diphenyl-1H-indol-6-yl)-,2-[(phenylamino)thioxomethyl]hydrazide

2-Propenoic acid, 3-[2-(methylseleno)-6-nitrophenyl]-

2-Propenoic acid, 3-[2-(1-methoxyethenyl)-1-cyclohexen-1-yl]-,1,1-dimethylethyl ester, (2E)-

2H-Indol-2-one,1-(3-bromophenyl)-1,3-dihydro-3,3-bis(4-hydroxy-3,5-dimethylphenyl)-

2H-Indol-2-one, 6-chloro-1,3-dihydro-3-hydroxy-3-(2-oxo-2-phenylethyl)-

2H-Indol-2-one,1,3-dihydro-3,3-bis(4-hydroxy-3,5-dimethylphenyl)-1-[2-(2-methoxyphenyl)-2-oxoethyl]-

2H-Quinolizine-1-carboxylic acid,7-(2,4-dichlorophenyl)-3,4,6,7,8,9-hexahydro-2-oxo-, methyl ester

2H-Tetrazole,2-[2-chloro-1-methyl-2,2-bis[4-(trifluoromethyl)phenyl]ethyl]-

2H-Indol-2-one, 3-amino-5-chloro-3-(2,5-dimethoxyphenyl)-1,3-dihydro-

2H-Indol-2-one, 5-[[(2-fluoro-6-nitrophenyl)methyl]sulfonyl]-1,3-dihydro-

2-Propenoic acid, 3-[2,2,2-trimethyl-1,1-bis(trimethylsilyl)disilanyl]-,octadecyl ester, (2Z)-

2-Propenoic acid, 3-[1-phenyl-3-(2-thienyl)-1H-pyrazol-4-yl]-,2-acetyl-4-fluorophenyl ester, (2E)-

2H-Indol-2-one, 5-chloro-1,3-dihydro-3-(1-naphthalenylimino)-

2H-Indol-2-one,1,3-dihydro-3,3-bis(4-hydroxy-3,5-dimethylphenyl)-1-[(2-methyl-4-thiazolyl)methyl]-

2-Propenoic acid, 3-[3-(1-tridecynyl)-2-furanyl]-, (E)-

2H-Indol-2-one, 5-[[(2,6-difluorophenyl)methyl]sulfonyl]-1,3-dihydro-

2H-Indol-2-one, 7-bromo-1,3-dihydro-3,3-diphenyl-

2H-Indol-2-one, 6-(2,4-dimethoxyphenyl)-1,3-dihydro-

2H-Indol-2-one,1,3-dihydro-3,3-bis(4-hydroxy-3,5-dimethylphenyl)-1-[[4-(trifluoromethyl)phenyl]methyl]-

2H-Indol-2-one,1-(2-cyclohexylethyl)-1,3-dihydro-3,3-bis(4-hydroxy-3,5-dimethylphenyl)-

2H-Indol-2-one, 5-acetyl-3-[(butylamino)phenylmethylene]-1,3-dihydro-

2-Propenoic acid, 3-[2,4-bis(2-propenyloxy)phenyl]-, ethyl ester

2-Propenoic acid, 3-[2-(4,5-dihydro-2-furanyl)-1-cyclohexen-1-yl]-,methyl ester, (2E)-

2H-Tetrazole, 2-[(phenylmethoxy)methyl]-5-(tributylstannyl)-

2H-Indol-2-one, 5-[[(3-fluorophenyl)methyl]sulfonyl]-1,3-dihydro-

2H-Indol-2-one,1,3-dihydro-3,3-bis(4-hydroxy-3,5-dimethylphenyl)-1-(4-pyridinyl)-

2-Propenoic acid, 3-[1-phenyl-3-(phenylmethoxy)-1H-pyrazol-5-yl]-,ethyl ester, (2E)-

2-Propenoic acid, 3-[3,4-bis[(ethoxycarbonyl)oxy]phenyl]-

2H-Quinolizine-2-carboxylic acid, octahydro-, ethyl ester, trans-

2H-Indol-2-one,1,3-dihydro-3,3-bis(4-hydroxy-3,5-dimethylphenyl)-1-[2-(2-pyridinyl)ethyl]-

2H-Tetrazol-5-amine, 2-(difluoromethyl)-

2H-Indol-2-one,1,3-dihydro-3,3-bis(4-hydroxy-3,5-dimethylphenyl)-5-methyl-1-[(2-phenyl-4-thiazolyl)methyl]-

2-Propenoic acid, 3-[1-phenyl-3-(2-thienyl)-1H-pyrazol-4-yl]-,2-acetyl-4-bromophenyl ester, (2E)-

2H-Indol-2-one, 3-[(6-chloro-3-pyridinyl)imino]-1,3-dihydro-1-phenyl-

2H-Indol-2-one,1,3-dihydro-3,3-bis(4-hydroxy-3,5-dimethylphenyl)-1-[[4-(phenylmethoxy)phenyl]methyl]-

2-Propenoic acid, 3-[3-[[[(1E)-2-phenylethenyl]sulfonyl]amino]phenyl]-,methyl ester, (2E)-

114566-52-8 msds

CAS No 114566-52-8 supplier

CASNo 114566-52-8 distributor

CAS # 114566-52-8 manufacturer

CAS Number 114566-52-8 safety

CAS RN 114566-52-8 wholesale

2026-10-11 Find 4-ethyl-6-(2-phenyl-1,3-thiazol-4-yl)-1,4-benzoxazin-3-one,CAS No.114566-52-8,Formula:C19H16N2O2S in 9CMX